Catalysts for Lannett Co Inc
120 tracked
Apr 15, 2026
drug shortage
Methylphenidate Hydrochloride Tablet, Extended Release shortage — Lannett Company, Inc.
Lannett Co Inc
→
Apr 15, 2026
drug shortage
Lisdexamfetamine Dimesylate Capsule shortage — Lannett Company, Inc.
Lannett Co Inc
→
Apr 15, 2026
drug shortage
Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet shortage — Lannett Company, Inc.
Lannett Co Inc
→
Mar 31, 2026
approval
VALPROIC ACID — FDA approval
VALPROIC ACID
→
Dec 23, 2025
approval
ORLYNVAH (PROBENECID) — FDA approval
Lannett Co Inc
→
Dec 22, 2025
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Dec 22, 2025
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Dec 22, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Dec 8, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Dec 8, 2025
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Oct 29, 2025
recall
Lannett Company Inc. recall (Cls II)
Lannett Co Inc
→
Oct 2, 2025
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Oct 2, 2025
approval
METADATE ER (METHYLPHENIDATE HYDROCHLORIDE) — FDA approval
METADATE ER
→
Sep 18, 2025
grant
BROWN UNIVERSITY — Probenecid for Alcohol Use Disorder
Lannett Co Inc
→
Sep 17, 2025
recall
Lannett Company Inc. recall (Cls II)
Lannett Co Inc
→
Sep 3, 2025
recall
Lannett Company Inc. recall (Cls II)
Lannett Co Inc
→
Mar 24, 2025
approval
ORLYNVAH (PROBENECID) — FDA approval
Lannett Co Inc
→
Feb 21, 2025
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Dec 11, 2024
recall
Lannett Company Inc. recall (Cls II)
Lannett Co Inc
→
Oct 31, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Oct 25, 2024
approval
ORLYNVAH (PROBENECID) — FDA approval
Lannett Co Inc
→
Mar 20, 2024
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Mar 13, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Dec 15, 2023
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Dec 15, 2023
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Dec 15, 2023
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Dec 15, 2023
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→